Speaker Details

Giuseppe Curigliano, MD, PhD, is the director of the Early Drug Development Division and holds the co-chair for Experimental Therapeutics Program at the European Institute of Oncology, a comprehensive cancer center in Milano, Italy. He is steering committee member of the Department of Oncology and Hemato-Oncology at the University of Milano. He is member of the Italian National Health Council, serving as advisor of the Ministry of Health for cancer policy issues. He worked at the Columbia University Comprehensive Cancer Center in New York, USA, developing an experience in preclinical and translational research. Professor Curigliano served as an expert panel member issuing the AIOM, ESMO, ASCO guidelines in breast cancer and germline gene testing recommendations. He co-chaired for several years the scientific committee of the St Gallen Early Breast Cancer Conference.